Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Anne Legnehed"'
Autor:
Birgitta Karlsson Svalstedt, Anders Thelin, Annika Wellner, Johanna Vinblad, Margareta Herslöf, David Gustafsson, Yantao Chen, Cristian Bodin, Ola Fjellström, Stefan Blaho, Jenny Sandmark, Carina Johansson, Birgitta Rosengren, Sofia Martinsson, Tomas Fex, Jonas Boström, Andreas Moberg, Tomas Akerud, Emma Evertsson, Bingze Xu, Ryan Hicks, Magnus Althage, Emelie Jarkvist, Wolfgang Knecht, Per-Olof Eriksson, Marianne Ridderström, Ann-Margret Östlund-Lindqvist, Anna Tigerström, Anders Dahlén, Anne Legnehed, Thomas Antonsson, Alan Sabirsh, Inge Kalies, Fredrik Kartberg
Publikováno v:
J Biol Chem
Increased plasma concentrations of lipoprotein(a) (Lp(a)) are associated with an increased risk for cardiovascular disease. Lp(a) is composed of apolipoprotein(a) (apo(a)) covalently bound to apolipoprotein B of low-density lipoprotein (LDL). Many of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acb534512cdcc56630f05e52c97ed62a
https://doi.org/10.1074/jbc.ra119.011251
https://doi.org/10.1074/jbc.ra119.011251
Autor:
Stefan Geschwindner, Jane McPheat, Carina Johansson, Viveca Nerme, Cristian Bodin, Anne Legnehed, Johanna Deinum, Tove Sjögren, Karolina Olsson, Amalia Paunovic, David Gustafsson, Ola Fjellström
Publikováno v:
Journal of Biological Chemistry. 288:873-885
A novel class of small molecule inhibitors for plasminogen activator inhibitor type 1 (PAI-1), represented by AZ3976, was identified in a high throughput screening campaign. AZ3976 displayed an IC(50) value of 26 μm in an enzymatic chromogenic assay
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8deedbdbe9dce2336446b34425126cce
https://doi.org/10.1074/jbc.m112.371732
https://doi.org/10.1074/jbc.m112.371732
Autor:
Lillemor Mattsson Hultén, Lena Amrot-Fors, Caroline Schmidt, Inge Kalies, David Gustafsson, Marianne Månsson, Göran Bergström, Wolfgang Knecht, Anne Legnehed
Publikováno v:
Scientific Reports
Lipoprotein (a) [Lp(a)] is a low density lipoprotein (LDL) with one apolipoprotein (a) molecule bound to the apolipoprotein B-100 of LDL. Lp(a) is an independent risk factor for cardiovascular disease (CVD). However, the relationship of Lp(a) to diab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5b1d96305402119a76f4bd47cae3209